Table 1 Baseline subject characteristics

From: Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults

Subject characteristic

Group A

Group B

All subjects combined

Sex (M/F)

5/7

6/6

11/13

Age (years)

64 ± 6

66 ± 9

65 ± 7

Mass (kg)

67 ± 16

69 ± 14

68 ± 15

BMI (kg m−2)

23 ± 4

24 ± 3

24 ± 4

Total body fat (%)

27 ± 10

29 ± 11

28 ± 10

Systolic blood pressure (mmHg)

122 ± 18

120 ± 17

121 ± 17

Diastolic blood pressure (mmHg)

77 ± 11

72 ± 9

74 ± 10

Fasting glucose (mg dl−1)

89 ± 8

87 ± 8

88 ± 8

Total cholesterol (mg dl−1)

192 ± 38

183 ± 36

187 ± 36

HDL cholesterol (mg dl−1)

69 ± 12

69 ± 25

69 ± 19

LDL cholesterol (mg dl−1)

107 ± 36

94 ± 23

101 ± 30

  1. Includes all subjects who completed the study (N = 24) by randomization group (A = placebo, NR; B = NR, placebo) and in all subjects combined. Data are mean ± SD.
  2. BMI body mass index, HDL high-density lipoprotein, LDL low-density lipoprotein
Back to article page